New hope for tough ovarian cancers: experimental drug ABBV-901 enters human testing
NCT ID NCT07278336
First seen Jan 05, 2026 · Last updated May 10, 2026 · Updated 22 times
Summary
This early-phase study tests an investigational drug called ABBV-901, given alone or with a standard drug (bevacizumab), in about 207 adults with advanced ovarian cancer that no longer responds to platinum chemotherapy. The main goals are to check safety and see if tumors shrink. Participants receive the drug through an IV and will have regular blood tests and scans over about 3 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hadassah Medical Center-Hebrew University /ID# 278420
RECRUITINGJerusalem, 91120, Israel
-
NEXT Oncology - San Antonio /ID# 278606
RECRUITINGSan Antonio, Texas, 78229, United States
-
Next Virginia /ID# 278607
RECRUITINGFairfax, Virginia, 22031, United States
-
Rambam Health Care Campus /ID# 278418
RECRUITINGHaifa, 3109601, Israel
-
Saitama Medical University International Medical Center /ID# 278437
RECRUITINGHidaka, Saitama, 350-1298, Japan
-
Shizuoka Cancer Center /ID# 278538
RECRUITINGSunto-gun, Shizuoka, 411-8777, Japan
-
Start Mountain Region /ID# 278609
RECRUITINGWest Valley City, Utah, 84119, United States
-
The Chaim Sheba Medical Center /ID# 278416
RECRUITINGRamat Gan, Tel Aviv, 5265601, Israel
Conditions
Explore the condition pages connected to this study.